Envestnet Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Envestnet Asset Management Inc holds 879,874 shares of TAK stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

879,874

Previous 891,183 1.27%

Holding current value

$12.2 Million

Previous $13.3 Million 2.65%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$13.71 - $15.46 $155,046 - $174,837	-11,309 Reduced 1.27%	879,874 $13.6 Million
Q1 2025 Apr 29, 2025	SELL	$12.89 - $15.19 $1.21 Million - $1.42 Million	-93,495 Reduced 9.49%	891,183 $13.3 Million
Q4 2024 Feb 12, 2025	SELL	$13.01 - $14.43 $6 Million - $6.65 Million	-460,843 Reduced 31.88%	984,678 $13 Million
Q3 2024 Nov 06, 2024	SELL	$13.0 - $15.08 $493,636 - $572,617	-37,972 Reduced 2.56%	1,445,521 $20.5 Million
Q2 2024 Aug 08, 2024	SELL	$12.6 - $13.67 $578,264 - $627,370	-45,894 Reduced 3.0%	1,483,493 $19.2 Million
Q1 2024 May 13, 2024	SELL	$13.89 - $15.04 $825,427 - $893,767	-59,426 Reduced 3.74%	1,529,387 $21.2 Million
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $1.01 Million - $1.17 Million	75,877 Added 5.02%	1,588,813 $22.7 Million
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $1.22 Million - $1.33 Million	81,267 Added 5.68%	1,512,936 $23.4 Million
Q2 2023 Aug 04, 2023	SELL	$15.57 - $17.11 $50.9 Million - $55.9 Million	-3,267,934 Reduced 69.54%	1,431,669 $22.5 Million
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $54.9 Million - $59.2 Million	3,593,286 Added 324.8%	4,699,603 $77.4 Million
Q4 2022 Feb 07, 2023	BUY	$12.42 - $15.62 $2.69 Million - $3.38 Million	216,445 Added 24.32%	1,106,317 $17.3 Million
Q3 2022 Nov 10, 2022	BUY	$12.8 - $28.65 $4.16 Million - $9.32 Million	325,262 Added 57.61%	889,872 $11.5 Million
Q2 2022 Aug 03, 2022	BUY	$13.12 - $15.03 $887,043 - $1.02 Million	67,610 Added 13.6%	564,610 $7.93 Million
Q1 2022 May 04, 2022	BUY	$13.54 - $15.35 $922,967 - $1.05 Million	68,166 Added 15.9%	497,000 $7.12 Million
Q4 2021 Feb 04, 2022	SELL	$13.17 - $16.4 $62,215 - $77,473	-4,724 Reduced 1.09%	428,834 $5.85 Million
Q3 2021 Oct 07, 2021	BUY	$16.3 - $17.26 $352,080 - $372,816	21,600 Added 5.24%	433,558 $7.1 Million
Q2 2021 Aug 04, 2021	SELL	$16.55 - $18.64 $580,325 - $653,611	-35,065 Reduced 7.84%	411,958 $6.93 Million
Q1 2021 May 04, 2021	BUY	$16.71 - $19.9 $310,922 - $370,279	18,607 Added 4.34%	447,023 $8.16 Million
Q4 2020 Feb 02, 2021	BUY	$15.39 - $18.97 $1.05 Million - $1.3 Million	68,397 Added 19.0%	428,416 $7.8 Million
Q3 2020 Oct 09, 2020	BUY	$17.1 - $19.19 $4,275 - $4,797	250 Added 0.07%	360,019 $6.42 Million
Q2 2020 Jul 08, 2020	BUY	$14.59 - $19.5 $61,774 - $82,563	4,234 Added 1.19%	359,769 $6.45 Million
Q1 2020 Apr 23, 2020	BUY	$13.02 - $20.31 $712,610 - $1.11 Million	54,732 Added 18.2%	355,535 $5.4 Million
Q4 2019 Feb 11, 2020	BUY	$16.88 - $20.83 $320,162 - $395,082	18,967 Added 6.73%	300,803 $5.94 Million
Q3 2019 Oct 17, 2019	BUY	$16.15 - $17.99 $457,335 - $509,440	28,318 Added 11.17%	281,836 $4.85 Million
Q2 2019 Aug 02, 2019	BUY	$16.58 - $20.49 $915,000 - $1.13 Million	55,187 Added 27.83%	253,518 $4.49 Million
Q1 2019 May 10, 2019	BUY	$16.7 - $21.52 $1.47 Million - $1.89 Million	87,781 Added 79.4%	198,331 $4.04 Million
Q4 2018 Feb 13, 2019	BUY	$15.64 - $21.1 $1.73 Million - $2.33 Million	110,550 New	110,550 $1.86 Million

Others Institutions Holding TAK

# of Institutions

368

Shares Held

73.1M

Call Options Held

1.68M

Put Options Held

157K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History